These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30815737)

  • 1. YAP and the Hippo pathway in cholangiocarcinoma.
    Sugihara T; Isomoto H; Gores G; Smoot R
    J Gastroenterol; 2019 Jun; 54(6):485-491. PubMed ID: 30815737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma.
    Ilyas SI; Yamada D; Hirsova P; Bronk SF; Werneburg NW; Krishnan A; Salim W; Zhang L; Trushina E; Truty MJ; Gores GJ
    J Biol Chem; 2016 Apr; 291(15):8031-47. PubMed ID: 26826125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy.
    Ma X; Zhou Y; Li R; Ding X; Li D; Pan T; Zhang F; Li W
    Mol Carcinog; 2024 Oct; 63(10):1866-1873. PubMed ID: 39092765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
    Conboy CB; Yonkus JA; Buckarma EH; Mun DG; Werneburg NW; Watkins RD; Alva-Ruiz R; Tomlinson JL; Guo Y; Wang J; O'Brien D; McCabe CE; Jessen E; Graham RP; Buijsman RC; Vu D; de Man J; Ilyas SI; Truty MJ; Borad M; Pandey A; Gores GJ; Smoot RL
    J Hepatol; 2023 Jan; 78(1):142-152. PubMed ID: 36162702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
    Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
    J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
    Cigliano A; Zhang S; Ribback S; Steinmann S; Sini M; Ament CE; Utpatel K; Song X; Wang J; Pilo MG; Berger F; Wang H; Tao J; Li X; Pes GM; Mancarella S; Giannelli G; Dombrowski F; Evert M; Calvisi DF; Chen X; Evert K
    J Exp Clin Cancer Res; 2022 Jun; 41(1):192. PubMed ID: 35655220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Hippo-YAP Signaling with Metabolism.
    Ibar C; Irvine KD
    Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
    Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
    Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
    Werneburg N; Gores GJ; Smoot RL
    Gene Expr; 2020 Jun; 20(1):67-74. PubMed ID: 31253203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of YAP by mechanical strain through Jnk and Hippo signaling.
    Codelia VA; Sun G; Irvine KD
    Curr Biol; 2014 Sep; 24(17):2012-7. PubMed ID: 25127217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
    Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting YAP and Hippo signaling pathway in liver cancer.
    Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
    Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of Hippo-YAP signaling pathway.
    Li S; Shi J; Wang L; Zhang D; Zhang H
    Biochem Biophys Res Commun; 2024 Jan; 692():149330. PubMed ID: 38048728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo-yap signaling in ocular development and disease.
    Lee M; Goraya N; Kim S; Cho SH
    Dev Dyn; 2018 Jun; 247(6):794-806. PubMed ID: 29532607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
    Tóth M; Wehling L; Thiess L; Rose F; Schmitt J; Weiler SME; Sticht C; De La Torre C; Rausch M; Albrecht T; Grabe N; Duwe L; Andersen JB; Köhler BC; Springfeld C; Mehrabi A; Kulu Y; Schirmacher P; Roessler S; Goeppert B; Breuhahn K
    BMC Cancer; 2021 Oct; 21(1):1079. PubMed ID: 34615513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
    Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
    Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.
    Vargas RE; Duong VT; Han H; Ta AP; Chen Y; Zhao S; Yang B; Seo G; Chuc K; Oh S; El Ali A; Razorenova OV; Chen J; Luo R; Li X; Wang W
    EMBO J; 2020 Jan; 39(1):e102406. PubMed ID: 31782549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
    Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
    Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo pathway in tissue homeostasis and regeneration.
    Wang Y; Yu A; Yu FX
    Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.